Skip to main content
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
116.35
+0.09 (0.08%)
At close: Feb 27, 2026, 4:00 PM EST
116.68
+0.33 (0.28%)
After-hours: Feb 27, 2026, 7:55 PM EST

Abbott Laboratories Revenue

In the year 2025, Abbott Laboratories had annual revenue of $44.33B with 5.67% growth. Abbott Laboratories had revenue of $11.46B in the quarter ending December 31, 2025, with 4.42% growth.

Revenue (ttm)
$44.33B
Revenue Growth
+5.67%
P/S Ratio
4.56
Revenue / Employee
$385,461
Employees
115,000
Market Cap
202.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202544.33B2.38B5.67%
Dec 31, 202441.95B1.84B4.59%
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medtronic 35.48B
Stryker 25.12B
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Boston Scientific 20.07B
Zimmer Biomet Holdings 8.23B
Edwards Lifesciences 6.07B
Smith & Nephew 5.94B
Revenue Rankings

ABT News

More News